Maternal alpha‐1‐antitrypsin as a noval marker for growth restriction in pre‐eclampsia

• Published in: The journal of obstetrics and gynaecology research 2021-12, Vol.47 (12), p.4250-4255
• Main Authors: Nori, Wassan, Ali, Alaa Ibrahim
• Format: Article
• Language: English
• Subjects: alpha‐1‐antitrypsin; Amniotic fluid; amniotic fluid index; Birth weight; Blood pressure; diagnosis; Eclampsia; Female; fetal growth restriction; Fetal Growth Retardation - diagnosis; Fetal Weight; fetal weight centile; Fetus; Humans; Inflammation; Platelets; Pre-Eclampsia - diagnosis; Preeclampsia; Pregnancy; pre‐eclampsia; Serum levels; Uric Acid
• ISSN: 1341-8076; 1447-0756
• DOI: 10.1111/jog.15043

Aim To verify the role of maternal serum levels of alpha‐1‐antitrypsin (AAT), an acute‐phase inflammatory protein, as a marker for distinguishing between fetal growth restriction (FGR) and normal birth weight in pre‐eclamptic women. We correlate serum AAT levels to the essential feto‐maternal parameters for an earlier and cost–benefit diagnostic method, thus distinguishing between FGR and normal birth weight in pre‐eclamptic women. Methods An observational study conducted at the University hospital recruited 100 pregnant women in 32/34 weeks of a singleton single tone pregnancy; all were pre‐eclampsia cases. All were tested by laboratory and ultrasound examination. Two sets of data were collected; one is maternal parameters such as blood pressure (BP), maternal serum AAT mean platelet volume (MPV), platelet distribution width (PDW), and serum uric acid levels, and the other is fetal parameters such as amniotic fluid index (AFI), fetal weight centile and estimated fetal weight. Results A strong negative correlation proved between serum levels of AAT and all study variables except fetal weight (systolic BP, diastolic BP, MPV, PDW, serum uric acid, fetal weight percentile, and AFI) with a correlation coefficient of; −0.95, −0.95, −0.85, −0.93, −0.91, −0.94, and −0.93 respectively. The cut‐off value for AAT 0.013 mg/ml showed the highest sensitivity and specificity as a diagnostic marker for FGR. Area under the curve was 0.99. Conclusions Negative correlations between maternal serum AAT and fetal parameters used to assess FGR were confirmed, suggesting that AAT is closely related to the pathophysiology of FGR among pre‐eclamptic patients and may serve as a helpful tool in distinguishing between FGR and normal birth weight babies, pending further validation in feto‐maternal outcomes.